May 16 (Reuters) - Pfizer ( PFE ) has agreed offer
payment of up to $250 million to settle more than 10,000
lawsuits in the United States over cancer risks associated with
its now-discontinued heartburn drug Zantac, the Financial Times
reported on Thursday.